Multiple Sclerosis
📧 Sign up to get email alerts when something new happens for Multiple Sclerosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2013-09-23Clinical Trial Update: Targeted Lower Extremity Joint Training [Phase 1, Phase 2]
A Phase 1/2 clinical trial investigating targeted lower extremity joint training for people with Multiple Sclerosis has been terminated.
-
CLINICAL_TRIALS research · 2013-09-16Clinical Trial Update: Avonex PEN Satisfaction and Patients Experience Clinical Trial
A completed study evaluating satisfaction and patient experience with Avonex PEN in people with multiple sclerosis.
-
CLINICAL_TRIALS research · 2013-08-08Clinical Trial Update: Effect of I-TRAVLE Training on Arm Function in MS and Chronic Stroke Patients [NA]
This clinical trial update evaluates the effect of I-TRAVLE Training on arm function in people with multiple sclerosis and chronic stroke.
-
CLINICAL_TRIALS research · 2013-05-17Clinical Trial Update: Investigation of GM Pathology Using Ultra High Field (7T) MRI Scanner
This clinical trial update describes a University of Nottingham study using ultra-high-field 7T MRI to investigate gray matter pathology in …
-
CLINICAL_TRIALS research · 2013-05-16Clinical Trial Update: MEsenchymal StEm Cells for Multiple Sclerosis [Phase 1, Phase 2]
Clinical trial update for mesenchymal stem cells as a potential therapy for multiple sclerosis in Phase 1/Phase 2, sponsored by Antonio Ucce…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2013-01-15Clinical Trial Update: Vitamine D in Multiple Sclerosis [Phase 3]
Phase 3 clinical trial evaluating Vitamin D for Multiple Sclerosis. The current status of the trial is unknown.
-
CLINICAL_TRIALS research · 2012-05-30Clinical Trial Update: Physical Activity and Fatigue in Early Multiple Sclerosis (MS)
Bayer-sponsored trial evaluating physical activity and fatigue in early multiple sclerosis has completed, marking an end to the study.
-
CLINICAL_TRIALS research · 2012-05-08Clinical Trial Update: Venous Irregularities, Flow and Perfusion in MS Study
A clinical trial studying venous irregularities, flow and perfusion in people with multiple sclerosis and non-MS participants. The current s…
-
CLINICAL_TRIALS research · 2012-05-03Clinical Trial Update: Psychometric Validation of Cognitive Endpoints
This clinical trial update reports the completed psychometric validation of cognitive endpoints for multiple sclerosis, evaluating the relia…
-
CLINICAL_TRIALS research · 2012-03-05Clinical Trial Update: A Prospective Study of Spasticity in Individuals With Multiple Sclerosis
This document reports on a prospective clinical study investigating spasticity in individuals with multiple sclerosis; the current trial sta…
-
CLINICAL_TRIALS research · 2011-08-08Clinical Trial Update: The Effects of Erythropoietin on Clinical Disability and Brain Pathology in Patients With Progressive Multiple Sclerosis [Phase 2]
This Phase 2 clinical trial update investigates the effects of erythropoietin on clinical disability and brain pathology in patients with pr…
-
CLINICAL_TRIALS research · 2011-04-25Clinical Trial Update: Evaluating Alemtuzumab as a Treatment in Stabilizing Neurocognitive Function In Relapsing Remitting Multiple Sclerosis Patients [Phase 3]
This entry provides an update on a Phase 3 clinical trial evaluating alemtuzumab for stabilizing neurocognitive function in relapsing-remitt…
-
CLINICAL_TRIALS research · 2011-04-12Clinical Trial Update: A Study to Evaluate Readiness to Self-inject on Adherence and Compliance to Copaxone® Therapy
A completed study evaluating readiness to self-inject and adherence to Copaxone therapy in people with multiple sclerosis.
-
CLINICAL_TRIALS research · 2010-12-01Clinical Trial Update: Study Comparing Corpus Callosum Atrophy as a Marker of Later Development of Cognitive Impairment in Patients With Multiple Sclerosis
This clinical trial update describes a study examining whether corpus callosum atrophy can predict subsequent cognitive impairment in patien…
-
CLINICAL_TRIALS research · 2010-07-13Clinical Trial Update: Novel Immune Markers in Patients With Multiple Sclerosis
A clinical trial update describing research on novel immune markers in patients with Multiple Sclerosis, sponsored by the University of Wash…
-
CLINICAL_TRIALS research · 2010-06-28Clinical Trial Update: Evaluation of Neural Loss in Multiple Sclerosis and Neuromyelitis Optica Using High Resolution Oct
A clinical trial update describing a study evaluating neural loss in multiple sclerosis and neuromyelitis optica using high-resolution optic…
-
CLINICAL_TRIALS research · 2010-06-24Clinical Trial Update: Validation of an Obstacle Course Used in Patients With Muscle Tightness
A clinical trial update from the Kessler Foundation on validating an obstacle course used to assess muscle tightness. The study includes par…
-
CLINICAL_TRIALS research · 2009-09-29Clinical Trial Update: Characteristic Study on Chinese Patients With Multiple Sclerosis [NA]
A characterization study describing Chinese patients with multiple sclerosis conducted by Sun Yat-sen University.
-
CLINICAL_TRIALS research · 2009-06-22Clinical Trial Update: Open-Label Natalizumab Safety Extension Study [Phase 3]
Open-label safety extension study of natalizumab in multiple sclerosis, a Phase 3 trial sponsored by Biogen; the study status is completed.
-
CLINICAL_TRIALS research · 2009-06-11Clinical Trial Update: Development and Evaluation of a New Palliative Care Service for People Severely Affected With Multiple Sclerosis (MS) [Phase 1, Phase 2]
A completed Phase 1/2 clinical trial evaluating a new palliative care service for people severely affected by multiple sclerosis.
-
CLINICAL_TRIALS research · 2009-03-12Clinical Trial Update: Diagnostic Study of Quantitative Imaging and Spectroscopy in Patients With Multiple Sclerosis
This document provides an update on a diagnostic study using quantitative imaging and spectroscopy in patients with multiple sclerosis.
-
CLINICAL_TRIALS research · 2009-02-20Clinical Trial Update: Safety Study of RTL1000 (Recombinant T Cell Receptor Ligand) in Subjects With Multiple Sclerosis [Phase 1]
Phase 1 safety study of RTL1000 in individuals with multiple sclerosis is described, with the current trial status listed as unknown.
-
CLINICAL_TRIALS research · 2009-01-05Clinical Trial Update: Far Infrared Irradiation for Managing and Treating Multiple Sclerosis (MS) [Phase 1]
Phase 1 clinical trial evaluating far infrared irradiation as a non-drug approach to managing and treating multiple sclerosis; the current s…
-
CLINICAL_TRIALS research · 2008-10-17Clinical Trial Update: Whole Body Vibration Therapy in a Participant With Multiple Sclerosis Related Balance Deficits - A Case Study [NA]
This is a completed case study evaluating whole body vibration therapy for balance deficits in a participant with multiple sclerosis. The re…
-
CLINICAL_TRIALS research · 2008-05-19Clinical Trial Update: A Randomized Placebo-Controlled, Crossover-Design Study of the Effects of Low Dose Naltrexone [Phase 3]
This clinical trial update describes a randomized, placebo-controlled, crossover Phase 3 study evaluating low-dose naltrexone in individuals…